CN1055501C - 重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗 - Google Patents

重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗 Download PDF

Info

Publication number
CN1055501C
CN1055501C CN92105030A CN92105030A CN1055501C CN 1055501 C CN1055501 C CN 1055501C CN 92105030 A CN92105030 A CN 92105030A CN 92105030 A CN92105030 A CN 92105030A CN 1055501 C CN1055501 C CN 1055501C
Authority
CN
China
Prior art keywords
virus
recombinant
sequence
plasmid
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92105030A
Other languages
English (en)
Chinese (zh)
Other versions
CN1069068A (zh
Inventor
G·蒂里
D·科劳
C·迪迈尼梅克
D·马拉米
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Dimminaco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco AG filed Critical Dimminaco AG
Publication of CN1069068A publication Critical patent/CN1069068A/zh
Application granted granted Critical
Publication of CN1055501C publication Critical patent/CN1055501C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CN92105030A 1991-05-27 1992-05-27 重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗 Expired - Fee Related CN1055501C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9100507 1991-05-27
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (2)

Publication Number Publication Date
CN1069068A CN1069068A (zh) 1993-02-17
CN1055501C true CN1055501C (zh) 2000-08-16

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92105030A Expired - Fee Related CN1055501C (zh) 1991-05-27 1992-05-27 重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗

Country Status (23)

Country Link
EP (1) EP0517292B1 (enExample)
JP (1) JP3411307B2 (enExample)
KR (1) KR100244601B1 (enExample)
CN (1) CN1055501C (enExample)
AR (1) AR248045A1 (enExample)
AT (1) ATE189480T1 (enExample)
AU (1) AU656185B2 (enExample)
BE (1) BE1004877A3 (enExample)
BR (1) BR9202024A (enExample)
CA (1) CA2069594A1 (enExample)
DE (1) DE69230627T2 (enExample)
DK (1) DK0517292T3 (enExample)
ES (1) ES2145000T3 (enExample)
HU (1) HU215531B (enExample)
IE (1) IE921686A1 (enExample)
IL (1) IL101780A (enExample)
MX (1) MX9202512A (enExample)
NZ (1) NZ242620A (enExample)
PT (1) PT517292E (enExample)
RU (1) RU2130971C1 (enExample)
SG (1) SG49876A1 (enExample)
TW (1) TW288048B (enExample)
ZA (1) ZA923321B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110505A1 (en) * 1991-07-26 1993-02-18 Enzo Paoletti Infectious bursal disease virus recombinant poxvirus vaccine
ATE286137T1 (de) * 1992-01-13 2005-01-15 Virogenetics Corp Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US7041439B2 (en) * 2001-04-17 2006-05-09 Embrex, Inc. Methods and apparatus for selectively processing eggs having identified characteristics
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
EP1450854A2 (en) 2001-11-30 2004-09-01 Isis Innovation Limited Vaccine
PL216760B1 (pl) * 2002-05-16 2014-05-30 Bavarian Nordic As Rekombinowany modyfikowany wirus krowianki Ankara oraz sposób jego otrzymywania i zastosowania
EP1601333B1 (en) * 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
EP2785373B1 (en) 2011-11-30 2019-11-20 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
CN113347992A (zh) 2018-12-27 2021-09-03 法国诗华大药厂 重组病毒和其用途
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
TWI812936B (zh) 2021-04-01 2023-08-21 智勝科技股份有限公司 研磨墊及研磨方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314569A1 (fr) * 1987-10-29 1989-05-03 Transgene S.A. Virus du fowlpox recombinant, vecteurs d'expression de protéines héterologues et vaccins pour la volaille dérivés de ce virus
EP0353851A1 (en) * 1988-06-24 1990-02-07 Btg International Limited Fowlpox virus non-essential regions
WO1990015140A1 (en) * 1989-05-30 1990-12-13 Commonwealth Scientific And Industrial Research Organisation Production of ibdv vp2 in highly immunogenic form

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
AU623476B2 (en) * 1988-12-29 1992-05-14 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314569A1 (fr) * 1987-10-29 1989-05-03 Transgene S.A. Virus du fowlpox recombinant, vecteurs d'expression de protéines héterologues et vaccins pour la volaille dérivés de ce virus
EP0353851A1 (en) * 1988-06-24 1990-02-07 Btg International Limited Fowlpox virus non-essential regions
WO1990015140A1 (en) * 1989-05-30 1990-12-13 Commonwealth Scientific And Industrial Research Organisation Production of ibdv vp2 in highly immunogenic form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J,VIROL,VOL,64,NO,2 1990.1.1 *

Also Published As

Publication number Publication date
ZA923321B (en) 1993-01-27
EP0517292A1 (fr) 1992-12-09
HUT62331A (en) 1993-04-28
AU656185B2 (en) 1995-01-27
IL101780A (en) 2000-12-06
ATE189480T1 (de) 2000-02-15
RU2130971C1 (ru) 1999-05-27
CA2069594A1 (fr) 1992-11-28
TW288048B (enExample) 1996-10-11
HU215531B (hu) 2000-05-28
EP0517292B1 (fr) 2000-02-02
DK0517292T3 (da) 2000-05-08
PT517292E (pt) 2000-06-30
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
MX9202512A (es) 1995-01-31
BE1004877A3 (fr) 1993-02-16
DE69230627T2 (de) 2000-09-28
ES2145000T3 (es) 2000-07-01
IL101780A0 (en) 1992-12-30
CN1069068A (zh) 1993-02-17
BR9202024A (pt) 1993-01-19
NZ242620A (en) 1993-09-27
JP3411307B2 (ja) 2003-05-26
DE69230627D1 (de) 2000-03-09
IE921686A1 (en) 1992-12-02
AR248045A1 (es) 1995-05-31
KR100244601B1 (ko) 2000-03-02
KR920021706A (ko) 1992-12-18
SG49876A1 (en) 2002-04-16
AU1632392A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
CN1055501C (zh) 重组禽痘病毒,培养被上述病毒感染的细胞以及从上述病毒得到的家禽疫苗
CN1056878C (zh) 重组火鸡疱疹病毒及其衍生的活载体疫苗
CN1195854C (zh) 猪环状病毒重组痘病毒疫苗
CN1077438C (zh) 重组球虫病疫苗
CN1620500A (zh) 包含功能性缺失的基因组的冠状病毒样颗粒
CN1020752C (zh) 后天性免疫缺乏综合征(爱滋病)疫苗
CN1018845B (zh) 病毒疫苗
CN1409765A (zh) 预防与猪环状病毒－2相关的心肌炎、流产和宫内感染
CN1437613A (zh) 修饰的麻疹病毒v蛋白
CN100335131C (zh) 重组火鸡疱疹病毒及其应用
CN1869243A (zh) 基于重组猪腺病毒的病毒载体和病毒疫苗
CN1653183A (zh) 表达插入痘病毒基因组中的同源基因的重组痘病毒
CN1214083A (zh) Hiv多包膜蛋白疫苗的重组痘苗载体混合物
CN1788077A (zh) 用于制备免疫保护性组合物的载体和来源于转基因植物的细胞
JPH02430A (ja) 組み換え家禽痘疹ウイルス
CN1218513A (zh) 基于重组缺损病毒基因组的载体及其在疫苗制剂中的应用
CN1217027A (zh) 含外源dna的副痘病毒,其制备及其在疫苗中的应用
CN1229358A (zh) 从合成的rna转录物制备双rna病毒的方法
MXPA01010273A (es) Novedosos herpesvirus recombinantes y mutantes.
CN1717488A (zh) 包含至少两个牛痘ati启动子的重组痘病毒
CN87106696A (zh) 蛋白质及其制备方法，adn的顺序，抗体及其用途，痘病病毒，被转化或感染的细胞用于预防血吸虫病的药剂组合物，以及作为谷胱甘肽-s-转移酶活性的显示剂的用途
CN1198918C (zh) 减毒的活胸膜肺炎放线杆菌
CN1495262A (zh) gp350/220的非剪接变异体
CN1192783A (zh) 马立克氏病病毒基因及其在抗马立克氏病的保护性疫苗中的应用
CN1537162A (zh) 减毒环状病毒

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: SOLVAY TO: DIMMINCO AG

CP03 Change of name, title or address

Address after: Adelisi, Switzerland

Applicant after: Dimminaco AG.

Address before: Brussels

Applicant before: Solvay & Cie

C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee